Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loading-dose Shexiang Tongxin Dripping Pills plus dual antiplatelet therapy before PCI in unstable angina
ChiCTR-IPR-16009785Phase 4Not yet recruiting
- Sponsor
- Xinhua Hospital
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Shexiang Tongxin Dropping Pills, aspirin and clopidogrel in acute coronary syndrome (ACS) and unstable angina (2 arms), sponsored by Xinhua Hospital. Primary endpoint: Platelet microparticles. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
Shexiang Tongxin Dropping Pillsaspirinclopidogrel
03
Conditions
acute coronary syndrome (ACS)unstable angina
Beyond the preview
Go deeper on ChiCTR-IPR-16009785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009785.